Decreased expression of BRCA2 accelerates sporadic breast cancer progression

被引:2
|
作者
Saha S. [1 ]
Mandal P. [1 ]
Ganguly S. [1 ]
Jana D. [1 ]
Ayaz A. [1 ]
Banerjee A. [1 ]
Chouhan R. [1 ]
Sarkar D.K. [1 ]
机构
[1] Departement of General Surgery, IPGME&R/SSKMH, 244, A.J.C Bose Road, Kolkata
关键词
BRCA2 decreased expression; Double Strand Break (DSB); Homology-directed Recombination (HR); Triple Negative Breast Cancer (TNBC);
D O I
10.1007/s13193-015-0449-1
中图分类号
学科分类号
摘要
Human tumor suppressor BRCA2 has been known to function in the repair of DNA double strand break. Germ line mutation in BRCA genes predisposes individuals to familial breast and ovarian cancer. The aim of present study was to characterize the implication of BRCA2 expression in cases of non−hereditary (sporadic) breast cancer. Female breast cancer patients aged between 20 and 75 years who underwent surgery were randomly selected. Patients with Stage IV disease at time of primary diagnosis or previous history of any other malignancy other than breast carcinoma or undergoing neoadjuvant chemotherapy were excluded from the study. Total 48 patients full filled these criteria. Patients were treated with either modified radical mastectomy or breast conservation therapy. Concentration of BRCA2 was measured by Sandwiched method of ELISA. Immunohistochemistry was used to determine the hormonal receptor status. Stage of the disease was not found to have any significant correlation on the BRCA2 expression. In patients with higher grade of tumors the level of BRCA2 expression was found to be low. Decreased expression of BRCA2 was found to be triple negative, had aggressive features and associated with higher chances of axillary metastasis. Genetic instability caused by decreased expression of BRCA2 could trigger mutations in sporadic breast cancer cases and mutations in turn leads to uncontrolled proliferation and invasive growth. © Indian Association of Surgical Oncology 2015.
引用
收藏
页码:378 / 383
页数:5
相关论文
共 50 条
  • [41] Breast and Prostate Cancer in a BRCA2 Carrier
    Mahar, Tara
    Hicks, David G.
    BREAST JOURNAL, 2012, 18 (05): : 511 - 513
  • [42] BRCA2 Mutation in Male Breast Cancer
    Santos, Filipa
    Felix, Ana
    Carvalho, Ana
    Machado, Patricia
    Andre, Saudade
    Vaz, Fatima
    LABORATORY INVESTIGATION, 2015, 95 : 64A - 65A
  • [43] Brca2 hereditary breast cancer pathophenotype
    Joseph N. Marcus
    Patrice Watson
    David L. Page
    Steven A. Narod
    Patricia Tonin
    Gilbert M. Lenoir
    Olga Serova
    Henry T. Lynch
    Breast Cancer Research and Treatment, 1997, 44 : 275 - 277
  • [44] Sensitivity to Taxane Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers Compared to Sporadic Breast Cancer Patients.
    Seynaeve, C.
    Jager, A.
    Hooning, M.
    den Bakker, M.
    Botenbal, M.
    Blom, J.
    Collee, M.
    van den Ouweland, A.
    Kriege, M.
    CANCER RESEARCH, 2009, 69 (24) : 624S - 625S
  • [45] Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics
    Egawa, C
    Miyoshi, Y
    Taguchi, T
    Tamaki, Y
    Noguchi, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (06): : 624 - 630
  • [46] The hunt for BRCA2 interactors scores a big hit: EMSY as a prognostic tool for sporadic breast cancer
    Slow, EJ
    CLINICAL GENETICS, 2004, 65 (04) : 261 - 262
  • [47] Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations
    Pristauz, Gunda
    Petru, Edgar
    Stacher, Elvira
    Geigl, Jochen B.
    Schwarzbraun, Thomas
    Tsybrovskyy, Oleksiy
    Winter, Raimund
    Moinfar, Farid
    HISTOPATHOLOGY, 2010, 57 (06) : 877 - 884
  • [48] Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients
    Hampl, JA
    Hampl, M
    Reiss, G
    Koch, R
    Saeger, HD
    Schackert, HK
    ANTICANCER RESEARCH, 2004, 24 (01) : 281 - 290
  • [49] Changes in BRCA2 expression during progression of the cell cycle
    Wang, SC
    Lin, SH
    Su, LK
    Hung, MC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (01) : 247 - 251
  • [50] Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer
    Edwards, SM
    Dunsmuir, WD
    Gillett, CE
    Lakhani, SR
    Corbishley, C
    Young, M
    Kirby, RS
    Dearnaley, DP
    Dowe, A
    Ardern-Jones, A
    Kelly, J
    Spurr, N
    Barnes, DM
    Eeles, RA
    INTERNATIONAL JOURNAL OF CANCER, 1998, 78 (01) : 1 - 7